Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib and Decitabine in Accelerated or Blastic Phase CML
NCT01498445Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2012
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in chronic myeloid leukemia (CML), acute myeloid leukemia (AML), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2012; status: terminated.
02
Drugs
decitabine
03
Conditions
chronic myeloid leukemia (CML)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01498445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498445.